Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rt-PA Dose-effect Relationship on ICH Evacuation
NCT02472574Phase 2Unknown
- Sponsor
- Tongji Hospital
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised trial of tissue-plasminogen activator in intracerebral hemorrhage (ICH) (3 arms), sponsored by Tongji Hospital. Primary endpoint: Rate of clot size removal. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02472574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472574.